Literature DB >> 21392548

A simple high-yielding process for transient gene expression in CHO cells.

Yashas Rajendra1, Divor Kiseljak, Lucia Baldi, David L Hacker, Florian M Wurm.   

Abstract

Here we describe a simplified method for transient gene expression (TGE) in suspension-adapted Chinese hamster ovary (CHO) cells using polyethylenimine (PEI) for DNA delivery. Both the transfection and production phases of the bioprocess were performed at a density of 4 × 10⁶ cells/mL at 31 °C. In addition, the amounts of both PEI and plasmid DNA were reduced up to 50% on a per cell basis compared to previously published protocols from this laboratory, resulting in higher cell viability after transfection and higher volumetric recombinant protein yields. In batch cultures of up to 14 days, reproducible recombinant antibody yields up to 300 mg/L were achieved at small scale (5 mL) and up to 250 mg/L at large scale (500 mL). The simplicity and improved yields are expected to increase the utility of CHO cells for the rapid production of recombinant proteins at larger scales by TGE.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21392548     DOI: 10.1016/j.jbiotec.2011.03.001

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  19 in total

1.  The need for innovation in biomanufacturing.

Authors:  Uwe Gottschalk; Kurt Brorson; Abhinav A Shukla
Journal:  Nat Biotechnol       Date:  2012-06-07       Impact factor: 54.908

2.  Glycosylation profiles determine extravasation and disease-targeting properties of armed antibodies.

Authors:  Dario Venetz; Christian Hess; Chia-wei Lin; Markus Aebi; Dario Neri
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 3.  Bridging the gap: facilities and technologies for development of early stage therapeutic mAb candidates.

Authors:  Trent P Munro; Stephen M Mahler; Edwin P Huang; David Y Chin; Peter P Gray
Journal:  MAbs       Date:  2011-09-01       Impact factor: 5.857

4.  A simple, rapid method for evaluation of transfection efficiency based on fluorescent dye.

Authors:  Lin Peng; Wendian Xiong; Yanfei Cai; Yun Chen; Yang He; Jianfeng Yang; Jian Jin; Huazhong Li
Journal:  Bioengineered       Date:  2016-09-27       Impact factor: 3.269

5.  Enhanced transient recombinant protein production in CHO cells through the co-transfection of the product gene with Bcl-xL.

Authors:  Matthew P Zustiak; Lisa Jose; Yueqing Xie; Jianwei Zhu; Michael J Betenbaugh
Journal:  Biotechnol J       Date:  2014-05-08       Impact factor: 4.677

Review 6.  Recent advances in mammalian protein production.

Authors:  Ashok D Bandaranayake; Steven C Almo
Journal:  FEBS Lett       Date:  2013-12-06       Impact factor: 4.124

7.  Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin.

Authors:  Patrizia Murer; Jonathan D Kiefer; Louis Plüss; Mattia Matasci; Sandra L Blümich; Marco Stringhini; Dario Neri
Journal:  J Invest Dermatol       Date:  2018-12-10       Impact factor: 8.551

8.  The targeted delivery of interleukin-12 to the carcinoembryonic antigen increases the intratumoral density of NK and CD8+ T cell in an immunocompetent mouse model of colorectal cancer.

Authors:  Emanuele Puca; Caroline Schmitt-Koopmann; Marius Furter; Patrizia Murer; Philipp Probst; Manuel Dihr; Davor Bajic; Dario Neri
Journal:  J Gastrointest Oncol       Date:  2020-08

9.  A novel dual-cytokine-antibody fusion protein for the treatment of CD38-positive malignancies.

Authors:  Roberto De Luca; Paul Kachel; Klara Kropivsek; Berend Snijder; Markus G Manz; Dario Neri
Journal:  Protein Eng Des Sel       Date:  2018-05-01       Impact factor: 1.650

10.  Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.

Authors:  Roberto De Luca; Alex Soltermann; Francesca Pretto; Catherine Pemberton-Ross; Giovanni Pellegrini; Sarah Wulhfard; Dario Neri
Journal:  Mol Cancer Ther       Date:  2017-07-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.